Risk assessment: Who is at risk of measles in the EU/EEA?
A large epidemic of measles has affected the EU/EEA Member States in the past three years, with 44 074 cases reported to ECDC by 30 Member States between 1 January 2016 and 31 March 2019.
Rapid risk assessment: outbreak of measles linked to a dog show in Slovenia, 8–9 November 2014
An outbreak of measles was reported in November 2014 from Slovenia. Of the 19 measles cases reported from Nova Gorica, Slovenia, 17 had a history of visiting an international dog show which took place on 8 and 9 November 2014.
Risk assessment: seasonal influenza 2011-2012 in Europe
The virological influenza pattern observed was not consistent enough to make a clear prediction for the 2011-2012 season in Europe. In general, the findings on the impact of influenza in the southern hemisphere in 2011 were reassuring for Europe, and the match of the A(H3N2) viruses with the vaccine was considered good.
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA - 1st update, 3 February 2016
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Risk assessment: Situation in northern Africa/Libyan Arab Jamahiriya and the influx of migrants* to Europe
ECDC, after conducting rapid risk assessments, has concluded that the risk of importation of infectious diseases from North Africa to the EU is considered to be low. From a public health perspective, the most urgent concern is related to the poor living conditions of the migrants, such as overcrowding and poor sanitation.
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA, 13 October 2015
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.